Gut microbiome in cirrhotic hepatitis C virus patients with and without hepatocellular carcinoma

Abstract Background Chronic hepatitis C is the most common cause of chronic liver disease and hepatocellular carcinoma in Egypt. A pathogenic link with gut microbial dysbiosis has been described in different diseases. The aim of the study is to elucidate changes in gut microbiome in cirrhotic HCV Eg...

Full description

Bibliographic Details
Main Authors: Khaled Mohieldeen, Soraya Abdel Fatah Hamoda, Shwikar Mahmoud Ahmed, Abdurrahman Najeeb, Walid Ismail Ellakany
Format: Article
Language:English
Published: SpringerOpen 2021-09-01
Series:Egyptian Liver Journal
Subjects:
Online Access:https://doi.org/10.1186/s43066-021-00147-y
_version_ 1818739878543753216
author Khaled Mohieldeen
Soraya Abdel Fatah Hamoda
Shwikar Mahmoud Ahmed
Abdurrahman Najeeb
Walid Ismail Ellakany
author_facet Khaled Mohieldeen
Soraya Abdel Fatah Hamoda
Shwikar Mahmoud Ahmed
Abdurrahman Najeeb
Walid Ismail Ellakany
author_sort Khaled Mohieldeen
collection DOAJ
description Abstract Background Chronic hepatitis C is the most common cause of chronic liver disease and hepatocellular carcinoma in Egypt. A pathogenic link with gut microbial dysbiosis has been described in different diseases. The aim of the study is to elucidate changes in gut microbiome in cirrhotic HCV Egyptian patients with and without HCC. Results The study included 50 cirrhotic HCV patients; 25 with and 25 without HCC and 25 healthy controls with matched age and sex. Stool specimens were taken from all participants. Quantitative SYBR Green real-time PCR technique targeting 16S rRNA was done for the identification and quantitation of selected bacterial phylum, genera, and/or species. Both HCC and cirrhosis groups showed decrease in Firmicutes, F/B ratio, A. mucinophilia, and F. prausnitzii compared to the control group. However, the HCC group only showed statistically significant increase in Bacteroides and Lactobacilli, and decrease of Prevotella relative abundance and P/B ratio compared to both cirrhosis and control groups. As regard the relation between the gut microbiome and stages of HCC, BCLC stage D showed significantly the lowest relative abundance of Ruminococcus. Conclusion Patients with HCV-related cirrhosis and HCC exhibit microbial dysbiosis; altered microbial relative abundance and diversity with HCC patients showing higher proinflammatory bacteria compared to cirrhotics.
first_indexed 2024-12-18T01:31:50Z
format Article
id doaj.art-9c83bef5157d4ffb82b00ae280d50eab
institution Directory Open Access Journal
issn 2090-6226
language English
last_indexed 2024-12-18T01:31:50Z
publishDate 2021-09-01
publisher SpringerOpen
record_format Article
series Egyptian Liver Journal
spelling doaj.art-9c83bef5157d4ffb82b00ae280d50eab2022-12-21T21:25:35ZengSpringerOpenEgyptian Liver Journal2090-62262021-09-011111910.1186/s43066-021-00147-yGut microbiome in cirrhotic hepatitis C virus patients with and without hepatocellular carcinomaKhaled Mohieldeen0Soraya Abdel Fatah Hamoda1Shwikar Mahmoud Ahmed2Abdurrahman Najeeb3Walid Ismail Ellakany4Tropical Medicine Department, Faculty of Medicine, Alexandria UniversityTropical Medicine Department, Faculty of Medicine, Alexandria UniversityMedical Microbiology and Immunology Department, Faculty of Medicine, Alexandria UniversityTropical Medicine Department, Faculty of Medicine, Alexandria UniversityTropical Medicine Department, Faculty of Medicine, Alexandria UniversityAbstract Background Chronic hepatitis C is the most common cause of chronic liver disease and hepatocellular carcinoma in Egypt. A pathogenic link with gut microbial dysbiosis has been described in different diseases. The aim of the study is to elucidate changes in gut microbiome in cirrhotic HCV Egyptian patients with and without HCC. Results The study included 50 cirrhotic HCV patients; 25 with and 25 without HCC and 25 healthy controls with matched age and sex. Stool specimens were taken from all participants. Quantitative SYBR Green real-time PCR technique targeting 16S rRNA was done for the identification and quantitation of selected bacterial phylum, genera, and/or species. Both HCC and cirrhosis groups showed decrease in Firmicutes, F/B ratio, A. mucinophilia, and F. prausnitzii compared to the control group. However, the HCC group only showed statistically significant increase in Bacteroides and Lactobacilli, and decrease of Prevotella relative abundance and P/B ratio compared to both cirrhosis and control groups. As regard the relation between the gut microbiome and stages of HCC, BCLC stage D showed significantly the lowest relative abundance of Ruminococcus. Conclusion Patients with HCV-related cirrhosis and HCC exhibit microbial dysbiosis; altered microbial relative abundance and diversity with HCC patients showing higher proinflammatory bacteria compared to cirrhotics.https://doi.org/10.1186/s43066-021-00147-yCirrhosisHepatitis C virusHepatocellular carcinomaGut dysbiosis
spellingShingle Khaled Mohieldeen
Soraya Abdel Fatah Hamoda
Shwikar Mahmoud Ahmed
Abdurrahman Najeeb
Walid Ismail Ellakany
Gut microbiome in cirrhotic hepatitis C virus patients with and without hepatocellular carcinoma
Egyptian Liver Journal
Cirrhosis
Hepatitis C virus
Hepatocellular carcinoma
Gut dysbiosis
title Gut microbiome in cirrhotic hepatitis C virus patients with and without hepatocellular carcinoma
title_full Gut microbiome in cirrhotic hepatitis C virus patients with and without hepatocellular carcinoma
title_fullStr Gut microbiome in cirrhotic hepatitis C virus patients with and without hepatocellular carcinoma
title_full_unstemmed Gut microbiome in cirrhotic hepatitis C virus patients with and without hepatocellular carcinoma
title_short Gut microbiome in cirrhotic hepatitis C virus patients with and without hepatocellular carcinoma
title_sort gut microbiome in cirrhotic hepatitis c virus patients with and without hepatocellular carcinoma
topic Cirrhosis
Hepatitis C virus
Hepatocellular carcinoma
Gut dysbiosis
url https://doi.org/10.1186/s43066-021-00147-y
work_keys_str_mv AT khaledmohieldeen gutmicrobiomeincirrhotichepatitiscviruspatientswithandwithouthepatocellularcarcinoma
AT sorayaabdelfatahhamoda gutmicrobiomeincirrhotichepatitiscviruspatientswithandwithouthepatocellularcarcinoma
AT shwikarmahmoudahmed gutmicrobiomeincirrhotichepatitiscviruspatientswithandwithouthepatocellularcarcinoma
AT abdurrahmannajeeb gutmicrobiomeincirrhotichepatitiscviruspatientswithandwithouthepatocellularcarcinoma
AT walidismailellakany gutmicrobiomeincirrhotichepatitiscviruspatientswithandwithouthepatocellularcarcinoma